| |
NMR in Biomedicine, Vol. 12, No. 3. (1999), pp. 123-138.
|
| |
Cancer Imaging, Vol. 6 (2006), pp. 95-99.
|
| |
The Lancet Oncology, Vol. 5, No. 9. (September 2004), pp. 531-540.
|
| |
J Nucl Med, Vol. 43, No. 8. (1 August 2002), pp. 1018-1027.
|
| |
Mol Imaging, Vol. 3, No. 1. (January 2004), pp. 1-8.
|
| |
Cancer Treatment Reviews, Vol. 29, No. 6. (December 2003), pp. 541-549.
by Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, et al.Hidetaka Uramoto, Yoichiro Yoshida, Mizuho Tanabe, Tomoko Ise, Tadashi Murakami, Takeshi Yoshida, Minoru Nomoto, Kimitoshi Kohno
|
| |
Anticancer Drugs, Vol. 6, No. 3. (June 1995), pp. 443-450.
|
| |
Cancer J, Vol. 9, No. 1. (b 2003), pp. 33-41.
by T. A. Buchholz, D. W. Davis, D. J. McConkey, et al.W. F. Symmans, V. Valero, A. Jhingran, S. L. Tucker, L. Pusztai, M. Cristofanilli, F. J. Esteva, G. N. Hortobagyi, A. A. Sahin
|
| |
Cancer, Vol. 89, No. 11. (2000), pp. 2145-2152.
|
| |
Novartis Found Symp, Vol. 240 (2001)
|
| |
Mol Cancer Ther, Vol. 2, No. 3. (March 2003), pp. 333-334.
|
| |
Biochem Pharmacol, Vol. 66, No. 7. (1 October 2003), pp. 1219-1229.
|
| |
Biochem Pharmacol, Vol. 66, No. 7. (1 October 2003), pp. 1207-1218.
|